Pimozide in Chronic Schizophrenic Patients

The Journal of Clinical Pharmacology and New Drugs

Volumn 11, Issue 4, 1971, Pages 304-309

  HUBER, WOLFGANG ^a,b   SERAFETINIDES, EUSTACE A ^a,b   COLMORE, JOHN P ^a,b   CLARK, MERVIN ^a,b  

^a University of Oklahoma Medical Center   (United States)

^b Griffin Memorial Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZIMIDAZOLE DERIVATIVE; PIPERIDINE DERIVATIVE; PLACEBO; THIORIDAZINE;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; EXTRAPYRAMIDAL SYSTEM; HALLUCINATION; HUMAN; IATROGENIC DISEASE; MALE; PSYCHOPHARMACOLOGY; RATING SCALE; SCHIZOPHRENIA; SOCIAL DESIRABILITY;

ADULT; ANALYSIS OF VARIANCE; BENZIMIDAZOLES; CHRONIC DISEASE; CLINICAL TRIALS; EXTRAPYRAMIDAL TRACTS; HALLUCINATIONS; HUMAN; MALE; PIPERIDINES; PLACEBOS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOPHARMACOLOGY; SCHIZOPHRENIA; SOCIAL DESIRABILITY; THIORIDAZINE;

EID: 0015092340     PISSN: 00219754     EISSN: 15524604     Source Type: Journal    
DOI: 10.1177/009127007101100410     Document Type: Article

References (6)

1. A multicentric clinical evaluation of pimozide
2. The brief psychiatric rating scale
3. The nurse's observation scale for inpatient evaluation (NOSIE). A new scale for measuring improvement in chronic schizophrenia
4. Termination of chlorpromazine with schizophrenic patients
5. Relapse in chronic schizophrenics following abrupt withdrawal of tranquilizing medication